Innate immune evasion strategies by human immunodeficiency virus type 1.

Debjani Guha, Velpandi Ayyavoo
Author Information
  1. Debjani Guha: Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, 130 Desoto Street, Pittsburgh, PA 15261, USA.

Abstract

Host immune components play both beneficial and pathogenic roles in human immunodeficiency virus type 1 (HIV-1) infection. During the initial stage of viral infection, a complex network of innate immune factors are activated. For instance, the immune cells express a number of inflammatory proteins including cytokines, chemokines, and antiviral restriction factors. These factors, specifically, interferons (IFNs) play a crucial role in antiviral defense system by modulating the downstream signaling events, by inducing maturation of dendritic cells (DCs), and by activation of macrophages, natural killer (NK) cells, and B and T cells. However, HIV-1 has evolved to utilize a number of strategies to overcome the antiviral effects of the host innate immune system. This review discusses the pathways and strategies utilized by HIV-1 to establish latent and persistent infection by defeating host's innate defense system.

References

  1. J Virol. 2004 Nov;78(21):12058-61 [PMID: 15479846]
  2. Nat Genet. 2007 Jun;39(6):733-40 [PMID: 17496894]
  3. Virus Res. 2002 Dec;90(1-2):275-86 [PMID: 12457982]
  4. J Leukoc Biol. 2003 Nov;74(5):719-25 [PMID: 12960239]
  5. Sci Rep. 2012;2:763 [PMID: 23094138]
  6. Science. 2007 Mar 16;315(5818):1579-82 [PMID: 17322031]
  7. EMBO J. 1998 Feb 16;17(4):1087-95 [PMID: 9463386]
  8. J Exp Med. 1996 Jan 1;183(1):307-10 [PMID: 8551237]
  9. Viruses. 2011 Jul;3(7):1179-203 [PMID: 21994776]
  10. Immunity. 2005 May;22(5):607-19 [PMID: 15894278]
  11. Curr Opin HIV AIDS. 2008 May;3(3):356-61 [PMID: 19372990]
  12. Curr HIV Res. 2003 Jul;1(3):295-307 [PMID: 15046254]
  13. Trends Mol Med. 2007 Nov;13(11):460-9 [PMID: 18029230]
  14. AIDS. 1995 Jan;9(1):19-26 [PMID: 7893437]
  15. PLoS Pathog. 2009 May;5(5):e1000429 [PMID: 19436700]
  16. Cell Host Microbe. 2008 Jun 12;3(6):388-98 [PMID: 18541215]
  17. Cell. 2003 Jun 13;113(6):803-9 [PMID: 12809610]
  18. Nat Immunol. 2010 Nov;11(11):1005-13 [PMID: 20871604]
  19. Antivir Ther. 2005;10(1):95-107 [PMID: 15751767]
  20. J Biol Chem. 1997 Mar 28;272(13):8388-95 [PMID: 9079663]
  21. J Immunol. 2002 Jan 1;168(1):95-101 [PMID: 11751951]
  22. Viruses. 2011 Jul;3(7):1204-9 [PMID: 21866272]
  23. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13153-8 [PMID: 9789057]
  24. J Virol. 2009 Aug;83(15):7536-46 [PMID: 19474106]
  25. J Immunol. 2006 Apr 1;176(7):3931-41 [PMID: 16547227]
  26. Ann Biol Clin (Paris). 1999 May;57(3):283-90 [PMID: 10377478]
  27. Mol Immunol. 1997 Aug-Sep;34(12-13):855-63 [PMID: 9464521]
  28. J Immunol. 2006 Sep 1;177(5):3469-76 [PMID: 16920989]
  29. PLoS Pathog. 2011 Feb;7(2):e1001284 [PMID: 21379343]
  30. AIDS Rev. 2011 Jan-Mar;13(1):3-12 [PMID: 21412385]
  31. J Biol Chem. 2004 Feb 27;279(9):7792-8 [PMID: 14672928]
  32. J Immunol. 2010 Mar 1;184(5):2369-76 [PMID: 20130213]
  33. J Infect Dis. 2005 May 1;191(9):1451-9 [PMID: 15809903]
  34. Science. 2004 Mar 26;303(5666):2019-22 [PMID: 15044802]
  35. Cell Host Microbe. 2009 Jul 23;6(1):54-67 [PMID: 19501037]
  36. J Neuroinflammation. 2012 Jun 22;9:138 [PMID: 22727020]
  37. J Immunol. 1998 Sep 15;161(6):2938-43 [PMID: 9743356]
  38. Virol J. 2005 Feb 28;2:17 [PMID: 15737233]
  39. AIDS. 2006 Jul 13;20(11):1549-51 [PMID: 16847410]
  40. AIDS Res Hum Retroviruses. 2004 Feb;20(2):175-82 [PMID: 15018705]
  41. J Exp Med. 2006 Oct 2;203(10):2339-50 [PMID: 17000867]
  42. Viruses. 2012 Sep 25;4(10):1844-64 [PMID: 23202444]
  43. Nature. 2007 Jul 26;448(7152):501-5 [PMID: 17618271]
  44. J Clin Invest. 1995 Sep;96(3):1520-6 [PMID: 7544808]
  45. Cell Signal. 2010 Jun;22(6):883-7 [PMID: 20043992]
  46. J Immunol. 2012 Apr 15;188(8):3876-85 [PMID: 22407919]
  47. Biochem Biophys Res Commun. 2004 Aug 27;321(3):566-73 [PMID: 15358144]
  48. Immunity. 1999 Jun;10(6):661-71 [PMID: 10403641]
  49. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401 [PMID: 17360657]
  50. Retrovirology. 2005 Oct 27;2:65 [PMID: 16253139]
  51. Int Arch Allergy Immunol. 1994;103(2):113-7 [PMID: 8292898]
  52. Exp Cell Res. 2002 May 1;275(2):243-54 [PMID: 11969293]
  53. Nucleic Acids Res. 2012 Mar;40(5):2181-96 [PMID: 22080513]
  54. Eur J Immunol. 2006 Sep;36(9):2424-33 [PMID: 16906533]
  55. Nat Rev Immunol. 2010 Jan;10(1):11-23 [PMID: 20010788]
  56. PLoS Pathog. 2008 Feb 29;4(2):e1000007 [PMID: 18389079]
  57. Curr Opin HIV AIDS. 2010 Mar;5(2):151-7 [PMID: 20543593]
  58. PLoS Pathog. 2010 Apr 08;6(4):e1000852 [PMID: 20386714]
  59. AIDS Res Hum Retroviruses. 1995 Aug;11(8):971-80 [PMID: 7492444]
  60. J Virol. 2008 Apr;82(8):3997-4006 [PMID: 18256146]
  61. J Leukoc Biol. 2004 Mar;75(3):504-14 [PMID: 14742635]
  62. Immunogenetics. 2002 Nov;54(8):527-42 [PMID: 12439615]
  63. Expert Opin Biol Ther. 2011 Jan;11(1):17-29 [PMID: 21133815]
  64. Curr HIV Res. 2003 Apr;1(2):205-16 [PMID: 15043203]
  65. AIDS Res Hum Retroviruses. 2010 Oct;26(10):1139-45 [PMID: 20722464]
  66. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4713-7 [PMID: 7515177]
  67. PLoS Pathog. 2006 May;2(5):e39 [PMID: 16699598]
  68. J Virol. 2000 Jun;74(12):5691-701 [PMID: 10823877]
  69. J Virol. 2004 May;78(10):5223-32 [PMID: 15113904]
  70. J Leukoc Biol. 2006 Nov;80(5):973-83 [PMID: 16908514]
  71. Antivir Chem Chemother. 2001 May;12(3):133-50 [PMID: 12959322]
  72. PLoS One. 2010 Jun 14;5(6):e11110 [PMID: 20559432]
  73. J Virol. 2009 Apr;83(8):3834-42 [PMID: 19193806]
  74. J Exp Med. 2007 Nov 26;204(12):3027-36 [PMID: 18025129]
  75. Blood. 2010 Feb 18;115(7):1354-63 [PMID: 20008788]
  76. J Virol. 2002 Apr;76(7):3179-88 [PMID: 11884542]
  77. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17453-8 [PMID: 17956986]
  78. Leukemia. 1999 Apr;13 Suppl 1:S99-105 [PMID: 10232380]
  79. Eur J Immunol. 2003 Aug;33(8):2098-107 [PMID: 12884283]
  80. Rev Med Virol. 2011 Jan;21(1):42-53 [PMID: 21294215]
  81. Blood. 2005 Mar 15;105(6):2458-64 [PMID: 15585654]
  82. Hum Immunol. 2002 Dec;63(12):1164-71 [PMID: 12480260]
  83. Nat Immunol. 2010 Nov;11(11):979-80 [PMID: 20959799]
  84. J Immunol. 2004 Sep 15;173(6):4236-41 [PMID: 15356175]
  85. J Virol. 2009 Apr;83(8):3719-33 [PMID: 19176632]
  86. J Virol. 2005 Oct;79(19):12365-74 [PMID: 16160163]
  87. Curr Opin HIV AIDS. 2011 Sep;6(5):348-52 [PMID: 21743322]
  88. J Interferon Res. 1986 Apr;6(2):143-52 [PMID: 2425014]
  89. Retrovirology. 2010 Dec 24;7:115 [PMID: 21184674]
  90. Annu Rev Immunol. 2003;21:265-304 [PMID: 12524385]
  91. Immunol Invest. 2004 May;33(2):157-72 [PMID: 15195695]
  92. Curr Top Microbiol Immunol. 2006;311:1-16 [PMID: 17048703]
  93. Nature. 2005 Aug 4;436(7051):740-4 [PMID: 15973356]
  94. Blood. 1994 Sep 15;84(6):1922-30 [PMID: 8080996]
  95. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10981-6 [PMID: 16046540]
  96. Immunol Rev. 1999 Apr;168:65-74 [PMID: 10399065]
  97. Blood. 2005 Nov 15;106(10):3366-9 [PMID: 16002429]
  98. Science. 2003 Nov 7;302(5647):1056-60 [PMID: 14564014]
  99. J Formos Med Assoc. 2011 Jun;110(6):350-62 [PMID: 21741003]
  100. Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7 [PMID: 18490657]
  101. Nature. 2011 Apr 21;472(7343):361-5 [PMID: 21512573]
  102. Curr Biol. 2005 Jan 26;15(2):166-70 [PMID: 15668174]
  103. Nature. 2011 Apr 21;472(7343):305-6 [PMID: 21512569]
  104. J Virol. 2009 Apr;83(8):3556-67 [PMID: 19193811]
  105. AIDS. 2010 Jul 31;24(12):1897-905 [PMID: 20543654]
  106. Cell Host Microbe. 2011 Jan 20;9(1):46-57 [PMID: 21238946]
  107. Antiviral Res. 1994 Jul;24(2-3):205-19 [PMID: 7526792]
  108. Cell. 2004 Jan 23;116(2):281-97 [PMID: 14744438]
  109. Eur J Immunol. 2003 Sep;33(9):2410-8 [PMID: 12938217]
  110. Nature. 2003 Jul 3;424(6944):99-103 [PMID: 12808466]
  111. PLoS One. 2011;6(7):e22730 [PMID: 21829495]
  112. Immunol Cell Biol. 2005 Oct;83(5):578-83 [PMID: 16174110]
  113. J Exp Med. 2009 Jun 8;206(6):1273-89 [PMID: 19487424]
  114. Cell Immunol. 2007 Nov-Dec;250(1-2):75-84 [PMID: 18334250]
  115. Gene Ther. 2008 Apr;15(7):545-52 [PMID: 18273055]
  116. Nat Med. 2003 Nov;9(11):1398-403 [PMID: 14528301]

Grants

  1. R01 MH087247/NIMH NIH HHS

Word Cloud

Created with Highcharts 10.0.0immunecellsHIV-1infectioninnatefactorsantiviralsystemstrategiesplayhumanimmunodeficiencyvirustype1numberdefenseHostcomponentsbeneficialpathogenicrolesinitialstageviralcomplexnetworkactivatedinstanceexpressinflammatoryproteinsincludingcytokineschemokinesrestrictionspecificallyinterferonsIFNscrucialrolemodulatingdownstreamsignalingeventsinducingmaturationdendriticDCsactivationmacrophagesnaturalkillerNKBTHoweverevolvedutilizeovercomeeffectshostreviewdiscussespathwaysutilizedestablishlatentpersistentdefeatinghost'sInnateevasion

Similar Articles

Cited By (25)